Breast Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are 18 years of age or older
• People who have been diagnosed with invasive breast cancer, confirmed through a biopsy or surgical sample
• People whose breast cancer can be treated with surgery
• People whose breast cancer is hormone receptor-positive (at least estrogen receptor-positive) and HER2-negative
• People who have already had an Oncotype DX (ODX) test performed on their tumour (a genetic test used to guide treatment decisions)

Who may not be able to join:

• People whose tumour cannot be surgically removed, or who are considered too unwell to safely undergo surgery
• People who have two breast cancers at the same time with different biological characteristics (for example, one hormone receptor-positive/HER2-negative tumour alongside a triple-negative or HER2-positive tumour)
• People who are currently receiving chemotherapy or hormone therapy before surgery (neoadjuvant therapy)
• People whose cancer has spread to more than 4 lymph nodes
• People whose breast cancer has already spread to other parts of the body at the time of diagnosis
• People who have been diagnosed with another cancer in the past 10 years (skin cancers other than melanoma are generally excepted — confirm with trial site)
• People who previously participated in the RxPONDER study in France
• People who have formally declined to participate in the study by submitting a refusal letter to the investigator
• People who do not have the legal capacity to consent to participation in a study

Important: Always verify eligibility with the trial site directly before applying.